Galmed Pharmaceuticals
GLMD
GLMD
31 hedge funds and large institutions have $24.5M invested in Galmed Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
10
Reduced
6
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$2K
Top Buyers
1 |
VC
Vivo Capital
Palo Alto,
California
|
+$2.98M |
2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.47M |
3 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$192K |
4 |
Squarepoint
New York
|
+$84.1K |
5 |
Goldman Sachs
New York
|
+$62K |